Ctt Pharmaceutical Holdings annual operating income
2010
2011
2012
2013
2014
2024
2025
Ctt Pharmaceutical Holdings Operating Income Growth & History (CTTH)
Ctt Pharmaceutical Holdings's operating income was −$153,903 for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$153,903 | $96,326 | — |
| 2024 | 2024-12-31 | −$250,229 | — | — |
| 2014 | 2014-12-31 | −$672,162 | −$653,251 | — |
| 2013 | 2013-12-31 | −$18,911 | $1.2M | — |
| 2012 | 2012-12-31 | −$1.2M | −$436,972 | — |
| 2011 | 2011-12-31 | −$757,935 | $1.3M | — |
| 2010 | 2010-12-31 | −$2.1M | — | — |
Ctt Pharmaceutical Holdings quarterly operating income
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q1.15
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$14,569 | $46,202 | — |
| Q1 2026 | 2026-03-31 | −$84,674 | −$55,172 | — |
| Q4 2025 | 2025-12-31 | −$48,251 | — | — |
| Q3 2025 | 2025-09-30 | −$15,379 | — | — |
| Q2 2025 | 2025-06-30 | −$60,771 | — | — |
| Q1 2025 | 2025-03-31 | −$29,502 | — | — |
| Q1 2015 | 2015-03-31 | −$337,052 | −$335,379 | — |
| Q2 2014 | 2014-06-30 | −$22,322 | $40,213 | — |
| Q1 2014 | 2014-03-31 | −$1,673 | $58,646 | — |
| Q4 2013 | 2013-12-31 | $129,681 | $431,722 | — |
| Q3 2013 | 2013-09-30 | −$25,738 | $92,788 | — |
| Q2 2013 | 2013-06-30 | −$62,535 | $128,987 | — |
| Q1 2013 | 2013-03-31 | −$60,319 | $522,499 | — |
| Q4 2012 | 2012-12-31 | −$302,041 | −$115,153 | — |
| Q3 2012 | 2012-09-30 | −$118,526 | −$11,106 | — |
| Q2 2012 | 2012-06-30 | −$191,522 | $245,247 | — |
| Q1 2012 | 2012-03-31 | −$582,818 | −$555,960 | — |
| Q4 2011 | 2011-12-31 | −$186,888 | — | — |
| Q3 2011 | 2011-09-30 | −$107,420 | $874,227 | — |
| Q2 2011 | 2011-06-30 | −$436,769 | −$51,142 | — |
| Q1 2011 | 2011-03-31 | −$26,858 | — | — |
| Q3 2010 | 2010-09-30 | −$981,647 | — | — |
| Q2 2010 | 2010-06-30 | −$385,627 | — | — |
Ctt Pharmaceutical Holdings operating income trends
Between the periods ended 2010-12-31 and 2025-12-31, Ctt Pharmaceutical Holdings's operating income increased from −$2.1M to −$153,903, a change of $1.9M. The latest reported quarter, Q2 2026, shows −$14,569.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗